Market Overview:
The global hepatitis B virus (HBV) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of hepatitis B, rising awareness about HBV and its prevention, and technological advancements in the field of diagnostics and therapeutics. The global HBV therapeutics market is segmented into antiviral drugs and immunotherapeutics. The antiviral drugs segment is further divided into nucleoside analogues, non-nucleoside analogues, and protease inhibitors. The immunotherapeutic segment includes therapeutic vaccines and passive immunity products such as hyperimmune globulins (HBIG) and pegylated interferon alpha (PEG-IFNα). Of these segments, the antiviral drugs segment is expected to account for the largest share of the global HBV therapeutics market in 2018. This can be attributed to factors such as increasing prevalence of chronic hepatitis B infection, growing demand for better treatment options, and rising awareness about available treatment options among patients with chronic hepatitis B infection. However, over time this trend is likely to change due to advances being made in therapeutic vaccine technology which are likely provide better long term outcomes for patients infected with HBV than current therapies available on the market .
 Industry Outlook.svg)
Product Definition:
Hepatitis B virus (HBV) is a type of virus that affects the liver. It can cause inflammation of the liver, called hepatitis, and can lead to serious health problems, including liver cancer. HBV is spread through contact with blood or other body fluids from an infected person. It can be prevented by getting vaccinated against it and by using precautions when coming into contact with blood or other body fluids from an infected person.
Therapeutics:
Therapeutics is the branch of medicine that deals with diseases caused by viruses, bacteria, fungus or parasites. The Hepatitis B Virus (HBV) is a contagious and potentially fatal viral infection of the liver. It is categorized as a member of the Herpes virus family and like all members of this family it can be transmitted through body fluids such as blood and semen.
Vaccine:
Vaccine is a preparation of antigen (body protein) that helps stimulate the immune system to fight off diseases. There are two types of vaccines: Inactivated (killed) and attenuated (weakened). The inactivated vaccine contains the active ingredient from a disease-causing virus or bacteria, while the attenuated vaccine uses an weakened form of this same substance.
The hepatitis B virus can cause liver cancer if not treated properly.
Application Insights:
Based on the application, the global hepatitis B virus (HBV) market is segmented into hospitals, ambulatory surgical centers and diagnostic centers. Hospitals held the largest share of HBV treatment due to increasing prevalence of chronic diseases such as HIV/AIDS, tuberculosis and HBV. In addition, hospital based settings are considered to be a primary transmission site for new infections owing to improper infection control practices in these settings. Thus rising number of patients visiting hospitals increases opportunities for new infections which is anticipated to drive demand over the forecast period.
The ambulatory surgical center segment is expected witness lucrative growth owing to growing awareness about preventable diseases coupled with favorable government regulations that favor cost-effective healthcare delivery systems in emerging economies such as India and China. Furthermore, an increase in number of ASCs has resulted in reduced turnaround time which has ultimately led towards improved patient satisfaction thereby driving demand over the forecast period. Vaccines are primarily used for immunization against hepatitis B virus (HBV).
Regional Analysis:
North America dominated the global hepatitis B virus market in 2017. This can be attributed to the presence of a large number of players, high awareness levels coupled with favorable government initiatives and reimbursement policies. The U.S., which is at the forefront, has one of the highest rates of infection worldwide with over 1 million people infected as per 2014 statistics published by CDC’s National Center for Health Statistics (NCHS).
The Asia Pacific region is expected to witness lucrative growth during the forecast period owing to increasing cases diagnosed in developing countries such as India and China along with other South East Asian nations. For instance, according to WHO data published in May 2018; around 170 thousand new infections were reported from India within a year (2017), making it one of the leading sources for new infections across globe.
Growth Factors:
- Increasing incidence of hepatitis B virus infection
- Growing awareness about the prevention and treatment of hepatitis B virus infection
- Rising demand for prophylactic and therapeutic vaccines against hepatitis B virus infection
- increasing number of patients suffering from chronic hepatitis B virus infection
- Technological advancements in the diagnosis and treatment of hepatitis b virus
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis B Virus (HBV) Market Research Report
By Type
Therapeutics, Vaccine
By Application
Hospitals, Ambulatory Surgical Centers, Diagnostic Centers
By Companies
Merck, Gilead Sciences, Novartis, GlaxoSmithKline, Hoffmann, La Roche, Bristol-Myers Squibb
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis B Virus (HBV) Market Report Segments:
The global Hepatitis B Virus (HBV) market is segmented on the basis of:
Types
Therapeutics, Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Gilead Sciences
- Novartis
- GlaxoSmithKline
- Hoffmann
- La Roche
- Bristol-Myers Squibb
 Market Overview.svg)
Highlights of The Hepatitis B Virus (HBV) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Therapeutics
- Vaccine
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis B Virus (HBV) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hepatitis B virus (HBV) is a virus that can cause liver disease. It is spread through contact with blood, saliva, or other body fluids from an infected person. HBV can also be spread through sexual contact with someone who has the virus. Symptoms of HBV include fever, fatigue, nausea, and vomiting. In severe cases, HBV can lead to liver failure and death.
Some of the major companies in the hepatitis b virus (hbv) market are Merck, Gilead Sciences, Novartis, GlaxoSmithKline, Hoffmann, La Roche, Bristol-Myers Squibb.
The hepatitis b virus (hbv) market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis B Virus (HBV) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis B Virus (HBV) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis B Virus (HBV) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis B Virus (HBV) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis B Virus (HBV) Market Size & Forecast, 2020-2028
4.5.1 Hepatitis B Virus (HBV) Market Size and Y-o-Y Growth
4.5.2 Hepatitis B Virus (HBV) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Therapeutics
5.2.2 Vaccine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Diagnostic Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis B Virus (HBV) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis B Virus (HBV) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Therapeutics
9.6.2 Vaccine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Diagnostic Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Therapeutics
10.6.2 Vaccine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Diagnostic Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Therapeutics
11.6.2 Vaccine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Diagnostic Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Therapeutics
12.6.2 Vaccine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Diagnostic Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Therapeutics
13.6.2 Vaccine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Diagnostic Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis B Virus (HBV) Market: Competitive Dashboard
14.2 Global Hepatitis B Virus (HBV) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Gilead Sciences
14.3.3 Novartis
14.3.4 GlaxoSmithKline
14.3.5 Hoffmann
14.3.6 La Roche
14.3.7 Bristol-Myers Squibb
